|
|
||||||||||||||
|
|
|||||||||||||||
BEST PRACTICE |
Royal Victoria Infirmary, Newcastle upon Tyne
Correspondence to:
Correspondence to:
Dr John Mansfield, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP; UK;
John.mansfield{at}nuth.northy.nhs.uk
ABSTRACT
The diagnosis of irritable bowel syndrome (IBS) is made on clinical grounds with appropriate limited investigations to exclude organic disease. IBS is common and may have a significant impact on a patients quality of life. Psychological symptoms are common. IBS may benefit from pharmacological and non-pharmacological management. Specific measures should be directed towards the dominant symptoms of constipation or diarrhoea. Several new drugs are currently under evaluation and may prove valuable for subgroups of patients with IBS. Successful management requires a combination of reassurance and explanation about the natural history of the condition.
Keywords: irritable bowel syndrome; functional bowel disease; psychosocial; fibre
Abbreviations: 5-HT3, serotonin-3; 5-HT4, serotonin-4; IBS, irritable bowel syndrome; SSRI, specific serotonin reuptake inhibitors
This article has been cited by other articles:
![]() |
M. J. Aaronson, J. R. Saltzman, and I. Nygaard Abdominal Pain, Bloating, and Urgency Obstet. Gynecol., April 1, 2005; 105(4): 889 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
K A Bergmann Update on irritable bowel syndrome Postgrad. Med. J., December 1, 2003; 79(938): 715 - 715. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |